Manzo Pharmaceut Total Asset vs. Cash And Equivalents

Based on Manzo Pharmaceut's profitability indicators, Manzo Pharmaceut may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Manzo Pharmaceut's ability to earn profits and add value for shareholders.

Manzo Pharmaceut Total Assets

164,511

For Manzo Pharmaceut profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Manzo Pharmaceut to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Manzo Pharmaceut utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Manzo Pharmaceut's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Manzo Pharmaceut over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Manzo Pharmaceut. If investors know Manzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Manzo Pharmaceut listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Manzo Pharmaceut is measured differently than its book value, which is the value of Manzo that is recorded on the company's balance sheet. Investors also form their own opinion of Manzo Pharmaceut's value that differs from its market value or its book value, called intrinsic value, which is Manzo Pharmaceut's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Manzo Pharmaceut's market value can be influenced by many factors that don't directly affect Manzo Pharmaceut's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Manzo Pharmaceut's value and its price as these two are different measures arrived at by different means. Investors typically determine if Manzo Pharmaceut is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Manzo Pharmaceut's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Manzo Pharmaceut Cash And Equivalents vs. Total Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Manzo Pharmaceut's current stock value. Our valuation model uses many indicators to compare Manzo Pharmaceut value to that of its competitors to determine the firm's financial worth.
JavaScript chart by amCharts 3.21.15FCGDITUPAHFDICTYMNZO 0200K400K600K800K1M1.2M1.4M 050K100K150K200K250K300K350K
Manzo Pharmaceut is considered to be number one stock in total asset category among its peers. It also is considered to be number one stock in cash and equivalents category among its peers . The ratio of Total Asset to Cash And Equivalents for Manzo Pharmaceut is about  9,162 . At this time, Manzo Pharmaceut's Total Assets are very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Manzo Pharmaceut's earnings, one of the primary drivers of an investment's value.

Manzo Cash And Equivalents vs. Total Asset

Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Manzo Pharmaceut

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
192.41 K
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Manzo Pharmaceut

Cash

 = 

Bank Deposits

+

Liquidities

 = 
21
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Manzo Cash And Equivalents Comparison

21.01.4M4.1K214.0100%
Manzo Pharmaceut is currently under evaluation in cash and equivalents category among its peers.

Manzo Pharmaceut Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Manzo Pharmaceut, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Manzo Pharmaceut will eventually generate negative long term returns. The profitability progress is the general direction of Manzo Pharmaceut's change in net profit over the period of time. It can combine multiple indicators of Manzo Pharmaceut, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-41.7 K-43.8 K
Net Loss-41.7 K-43.8 K
Income Before Tax-41.7 K-43.8 K
Total Other Income Expense Net-1.1 M-1.2 M
Net Loss-41.7 K-43.8 K
Net Loss-41.7 K-43.8 K
Change To Netincome280.8 K361.1 K

Manzo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Manzo Pharmaceut. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Manzo Pharmaceut position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Manzo Pharmaceut's important profitability drivers and their relationship over time.

Use Manzo Pharmaceut in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Manzo Pharmaceut position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Manzo Pharmaceut will appreciate offsetting losses from the drop in the long position's value.

Manzo Pharmaceut Pair Trading

Manzo Pharmaceut Pair Trading Analysis

The ability to find closely correlated positions to Manzo Pharmaceut could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Manzo Pharmaceut when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Manzo Pharmaceut - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Manzo Pharmaceut to buy it.
The correlation of Manzo Pharmaceut is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Manzo Pharmaceut moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Manzo Pharmaceut moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Manzo Pharmaceut can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Manzo Pharmaceut position

In addition to having Manzo Pharmaceut in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Global Macro ETFs Thematic Idea Now

Global Macro ETFs
Global Macro ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Manzo Pharmaceut offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Manzo Pharmaceut's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Manzo Pharmaceut Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Manzo Pharmaceut Stock:
Check out Correlation Analysis.
To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
To fully project Manzo Pharmaceut's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Manzo Pharmaceut at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Manzo Pharmaceut's income statement, its balance sheet, and the statement of cash flows.
Potential Manzo Pharmaceut investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Manzo Pharmaceut investors may work on each financial statement separately, they are all related. The changes in Manzo Pharmaceut's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Manzo Pharmaceut's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.